TCR2 Therapeutics is a clinical-stage immunotherapy company based in Cambridge, Massachusetts, and focused on developing T-cell therapies for solid tumors and hematological malignancies. Connect with a Mesothelioma Doctor
(617) 949-5200 Company Description: Tcr2 Therapeutics Inc. is located in Cambridge, MA, United States and is part of the Offices of Other Health Practitioners Industry. Tcr2 Therapeutics Inc. has 46 total employees across all of its locations. There are 2 companies in the Tcr2 Therapeutics Inc. corporate family.
TCR² is a clinical-stage immunotherapy company developing a new generation of T cell therapies for patients suffering from cancer. Our proprietary TRuC™ (TCR Fusion Construct) T cells harness the natural T cell receptor complex to recognize and kill cancer cells using the full power of T cell signaling pathways independent of HLA.
Description. At TCR2 Therapeutics we have a bold vision – to cure cancer by using our immune system in a more natural way. We have developed a unique proprietary TRuC™ platform based on T cell receptor fusion constructs that have the advantage of employing the full signaling power inherent to a complete T cell receptor (TCR).
Get an in-depth profile of Tcr2 Therapeutics Inc, including a general overview of the company's business and key management, as well as employee ...